Skip to main content
. 2017 Aug 28;16(5):5807–5814. doi: 10.3892/mmr.2017.7366

Figure 1.

Figure 1.

EAS enhances the viability of TNF-α-treated chondrocytes. Chondrocytes were treated with or without TNF-α, and with or without EAS, for 24, 48 and 72 h, and an MTT assay was performed to detect cell viability. Data are presented as the mean ± standard deviation. ▲▲P<0.01 compared with the control group; P<0.05 compared with the model group. EAS, electroacupuncture serum; TNF-α, tumor necrosis factor-α.